Introduction
============

Coronary artery bypass grafting (CABG) is one of the main methods for surgical treatment of heart disease. Most patients undergoing CABG are in severe condition. They all have different degrees of cardiac damage, and are particularly sensitive to anesthetic drugs, complications are easy to occur and are affecting their postoperative outcome ([@b1-etm-0-0-6993],[@b2-etm-0-0-6993]). Off-pump coronary artery bypass grafting (OPCABG) can effectively reduce postoperative serious complications, so it has been widely used in clinical practice, but OPCABG will bring obvious stress response to patients, cutting the sternum in the operation especially increases stress response, leading to hemodynamic changes in patients, and the emergence of inflammatory reactions, easily lead to systemic inflammatory response syndrome. Anesthetic drugs can also lead to neurological and cognitive functional complications ([@b3-etm-0-0-6993],[@b4-etm-0-0-6993]). Malondialdehyde (MDA) is the final metabolite of oxidative stress and can reflect the level of oxidative stress ([@b5-etm-0-0-6993]). β-endorphin (β-EP) can play an important role in analgesia ([@b6-etm-0-0-6993]). Sevoflurane is a new type of inhalation anesthetic gas, it can reduce myocardial ischemia/reperfusion injury, and play a protective role on the myocardium, and has a role on internal environment changes and the course of disease of CABG perioperative patients ([@b7-etm-0-0-6993]). In this study, OPCABG patients were given anesthesia by different anesthesia methods to explore their impact on hemodynamics, inflammation, and postoperative outcomes.

Patients and methods
====================

### General Information

During the period from March 2017 to February 2018, 94 patients undergoing coronary artery bypass surgery in Jining No. 1 People\'s Hospital (Jining, China) were included. Inclusion criteria were: i) heart function at Class II--III according to New York Heart Association; ii) all performed OPCABG and complete medical records and iii) signed informed consent. Exclusion criteria were: i) severe renal insufficiency, history of heart failure, and coagulation dysfunction; ii) brain organic disease and severe physical disease and iii) drug allergies. Random number table method was used to divide patients into the control (47 cases) and observation groups (47 cases). There was no significant difference in general data between the two groups (P\>0.05), and the data were comparable ([Table I](#tI-etm-0-0-6993){ref-type="table"}).

The study was approved by the Ethics Committee of Jining No. 1 People\'s Hospital. Patients who participated in this study, signed the informed consent and had complete clinical data.

### Anesthesia method

Both groups of patients fasted for 8 h before surgery. After entering the operating room, the mask was given pure oxygen (6 l/min) to make the blood oxygen saturation above 98%, and the patient\'s peripheral veins were opened. Patients in the control group were given fentanyl (5 µg/kg) and vecuronium bromide (0.1 mg/kg) for induction of anesthesia. If BIS value was below 55, patients were intubated and connected to the ventilator (respiration rate: 12--15 times/min, inhalation ratio was 1:2, tidal volume was 8--9 ml/kg), and propofol (3 mg/kg/h) and fentanyl (5 µg/kg/h) were used to maintain anesthesia.

In the observation group, the induction of anesthesia was the same as in the control group. Inhalation of sevoflurane (concentration 3 to 4%) continued after tracheal intubation, and sevoflurane was adjusted according to changes in the depth of anesthesia (BIS value).

### Detection of related indicators

Serum MDA concentration was measured by thiobarbituric acid (TBA) before and during surgery. β-EP levels in serum were detected by enzyme-linked immunosorbent assay (ELISA). The kits were all provided by Nanjing Bioengineering Research, the operation was in strict accordance with the instructions, the OD value was measured by a microplate reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA) at a wavelength of 532 nm, and the MDA content in the serum was calculated. The OD value was read using a microplate reader (Bio-Rad Laboratories, Inc.) at a wavelength of 450 nm, and the corresponding β-EP concentration level was calculated.

Peripheral venous blood (4 ml) was collected before surgery and 3, 5, and 7 days after surgery. The sample was centrifuged at 3,000 × g 4°C for 15 min and the supernatant was stored at −70°C. The levels of CRP, TNF-α and IL-6 were detected by ELISA. The kits were all provided by American RB. They were operated strictly in accordance with the instructions. OD values were read at a wavelength of 450 nm using a microplate reader to calculate the concentrations of CRP, TNF-α and IL-6.

### Evaluation methods

Mean heart rate (HR), mean arterial pressure (MAP), Systemic Vascular Resistance Index (SVRI) and Heart Index (CI) in the two groups immediately before induction of anesthesia (T1), 2 min after sawing the sternum (T2), after the start of bypass of the coronary artery (T3), and at the end of bypass (T4) were measured.

The level of MDA was measured by TBA method and β-EP level was measured by ELISA. The inflammatory factors (CRP, TNF-α, IL-6) were measured by ELISA before and 3, 5, and 7 days after operation. Adverse reactions were observed in both groups, including nausea and vomiting, hypoxemia, delay in wakefulness, and postoperative agitation. Postoperative eating time, ambulation time and hospital stay were observed and recorded.

Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA) Scale (Spatial and Executive Ability, Memory, Attention, Naming, Language, Delayed Recall, Abstract Thinking, and Directional Rating in 8 Fields) ([@b8-etm-0-0-6993]) and Mini Mental State Examination (MMSE) Scales (score, language, recall, attention and computational power) ([@b9-etm-0-0-6993]) 1 day before and after surgery. The scores were negatively correlated with the degree of cognitive impairment.

### Statistical analysis

The data were processed using SPSS 19.0 (SPSS Inc., Chicago, IL, USA) software. Measurement data were expressed as mean ± standard deviation and t-test was used. The enumeration data were expressed as a rate, and ANOVA was used for multiple comparisons with Tukeys test. P\<0.05 for the difference was statistically significant.

Results
=======

### Comparison of hemodynamic parameters between different anesthesia patients

There were no significant differences in HR, MAP, SVRI and CI between the two groups at different times (P\>0.05) ([Table II](#tII-etm-0-0-6993){ref-type="table"}).

### Comparison of the levels of β-EP and MDA in both groups

Both β-EP and MDA in the two groups during operation were higher than before operation. The level of β-EP in the observation group was higher than that in the control group, and the level of MDA was lower in the observation group than in the control group (P\<0.05) ([Table III](#tIII-etm-0-0-6993){ref-type="table"}).

### Comparison of adverse reactions after surgery

There was no significant difference in the incidence of nausea and vomiting, hypoxemia, postoperative restlessness and delayed awakening between the two groups (P\>0.05), as shown in [Table IV](#tIV-etm-0-0-6993){ref-type="table"}.

### Comparison of inflammation index

There was no significant difference in CRP, TNF-α, and IL-6 between the two groups before surgery (P\>0.05). There was a significant increase after surgery in the two groups, and the control group was more significant than the observation group (P\<0.001) ([Tables V](#tV-etm-0-0-6993){ref-type="table"}--[VII](#tVII-etm-0-0-6993){ref-type="table"}).

### Comparison of the outcome of the two groups

The eating time and the time of getting out of bed in the observation group were significantly earlier than those in the control group, and the length of stay in the observation group was significantly shorter than that in the control group (P\<0.05) ([Table VIII](#tVIII-etm-0-0-6993){ref-type="table"}).

### Comparison of the MoCA and MMSE scores of the two groups

The MoCA and MMSE scores of both groups after surgery were lower than those before surgery, and the decrease in the observation group was lower than in the control group (P\<0.05) ([Table IX](#tIX-etm-0-0-6993){ref-type="table"}).

Discussion
==========

Off-pump coronary artery bypass grafting (OPCABG) is a cardiac surgery method developed in recent years, it can avoid cardiopulmonary bypass, so the incidence of serious complications after surgery is greatly reduced, and it is widely recognized in the clinic. When OPCABG is performed, it needs to be performed with the heart beating continuously. Therefore, the difficulty of the operation is increased, and the requirement for anesthesia is higher than that of CABG. Therefore, seeking the best anesthesia has a significant importance on the surgical outcome and postoperative outcome of OPCABG patients.

Sevoflurane is a new safe and effective inhalation halogenated volatile anesthetic with the smallest gas partition coefficient. It is widely used in cardiac surgery and its effectiveness and safety have been confirmed ([@b10-etm-0-0-6993]). The results of this study showed that there was no significant difference in perioperative HR, MAP, SVRI, and CI between the two groups (P\>0.05). This shows that the combination of sevoflurane inhalation and combined anesthesia does not cause abnormal hemodynamic changes in the patient compared with routine anesthesia.

OPCABG is one of the most common major cardiac surgery operations. Perioperative patients can cause severe stress reactions. Especially when the sternum was cut and the aortic wall was clamped, the strong stimulation of the injury site was the main cause of the perioperative stress response of OPCABG. How to suppress this strong stimulation and regulate the patient\'s stress response is one of the main tasks of anesthesia ([@b11-etm-0-0-6993]). MDA is an oxidative stress product with strong cytotoxicity, and its concentration level directly reflects the rate and intensity of lipid peroxidation *in vivo* ([@b12-etm-0-0-6993]). β-EP is an inhibitory transmitter that regulates pain pathways and plays an important role in analgesia ([@b13-etm-0-0-6993]). The results of this study showed that both β-EP and MDA were elevated in the two groups during the operation compared with before surgery. The level of β-EP in the observation group was higher than that in the control group, and the level of MDA was lower in the observation group than in the control group (P\<0.05). It is because during OPCABG, surgical operations and anesthetic drug stimulation lead to the patient\'s stress response, oxygen free radicals are damaged, an imbalance occurs in the body\'s redox reaction, resulting in oxidative stress, leading to increased MDA levels. In contrast to fentanyl and propofol anesthetics, sevoflurane inhibits the release of sensory-transmitter substance P and promotes the secretion of large amounts of β-EP from the pituitary gland, which plays a positive feedback role in the analgesic pathway; sevoflurane can effectively scavenge oxygen free radicals, thereby reducing MDA levels.

The wounds of OPCABG cause systemic stress responses in the patient, altering the body\'s neuroendocrine-immune regulatory network, and leading to abnormal changes in catechol, which in turn stimulates the massive secretion of inflammatory cytokines ([@b14-etm-0-0-6993]). CRP is an acute phase reaction protein and is one of the indicators of the inflammatory response ([@b15-etm-0-0-6993]). TNF-α can initiate and trigger inflammatory reactions that can lead to necrosis of tumor cells, but also has anti-infective and immunomodulatory effects ([@b16-etm-0-0-6993]). IL-6 is an acute phase reactive lymphocyte factor that can play a diversified role in the inflammatory response ([@b17-etm-0-0-6993]). The results of this study showed that serum CRP, TNF-α, and IL-6 levels were significantly elevated in both groups of patients after surgery, and the increase was significantly higher in the control group than in the observation group (P\<0.05). This is because OPCABG, as a major operation, is combined with immune response in order to release all kinds of inflammatory mediators. Therefore, the levels of CRP, TNF-α and IL-6 will increase, sevoflurane can reduce ischemia/reperfusion injury and protect the myocardium, thus reducing myocardial oxygen consumption, without reducing the blood flow of the myocardium and alleviating the accumulation of neutrophils in the body, the effect of inhibiting various inflammatory factors can be achieved.

After major operations, especially after anesthesia, patients develop intellectual disabilities such as social skills, memory, and orientation disability ([@b18-etm-0-0-6993]). The various discomforts in the recovery after OPCABG may lead to excessive sympathetic nerve tension in the patient and sensitization of the central nervous system. With the release of a large number of inflammatory factors, it migrates through the blood-brain barrier and causes an inflammatory reaction in the hippocampus of the brain, therefore, generating cognitive dysfunction ([@b19-etm-0-0-6993]). The results of this study showed that both MoCA and MMSE scores decreased after surgery in both groups, and that the decrease in the observation group was significantly lower (P\<0.05) compared with the control group. This is because anesthesia causes neuronal morphology and biological changes, leading to loss and apoptosis of neurons, easy to produce cognitive dysfunction, and sevoflurane has the advantages of no irritating stimuli, rapid induction of awakening, easy control of the depth of anesthesia, prevents intracellular Ca^2+^ overload to reduce or avoid neuronal necrosis, and plays a protective role in dealing with ischemic neuronal injury, thereby improving the expression of neurotrophic factors in the dentate gyrus of the hippocampus, and reducing the degree of inflammatory reactions in the hippocampus, thereby reducing the incidence of cognitive dysfunction, and has a positive promotion role in the rapid recovery of patients ([@b20-etm-0-0-6993]).

In summary, compared with fentanyl and propofol anesthetic drugs, sevoflurane inhalation combined anesthesia has a significant effect on reducing stress response and reducing postoperative inflammatory reactions and cognitive dysfunction. It is beneficial to the patient\'s postoperative outcome and has certain clinical application value.
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###### 

Baseline data of two groups of patients.

  Items                       Observation group n=47   Control group n=47   t/χ^2^ value   P-value
  --------------------------- ------------------------ -------------------- -------------- ---------
  Sex (Male/Female)           29/18                    27/20                0.044          0.833
  Age (year)                  20--38                   20--40                              
  Average age (year)          29.46±6.42               28.85±6.63           0.453          0.652
  BMI (kg/m^2^)               22.03±1.45               22.16±1.38           0.445          0.657
  NYHA heart function (n,%)                                                                
    Class II                  17 (36.17)               20 (42.55)           0.178          0.673
    Class III                 30 (63.83)               27 (57.45)                          
    Operation time (min)      201.54±13.17             202.43±13.36         0.325          0.746

###### 

Comparison of hemodynamic parameters at different time periods.

  Indexes                     Group         No. of cases   T1               T2               T3               T4
  --------------------------- ------------- -------------- ---------------- ---------------- ---------------- ----------------
  HR (time)                   Observation   47             75.53±3.36       74.85±3.62       68.15±3.35       71.82±3.73
                              Control       47             75.08±3.72       75.14±3.53       67.93±3.38       71.17±3.45
  MAP (mmHg)                  Observation   47             77.16±3.48       74.82±3.32       72.63±3.29       78.08±3.37
                              Control       47             77.13±3.36       74.76±3.38       72.45±3.32       78.14±3.35
  SVRI (dynes-s/cm^5^/m^2^)   Observation   47             2,638.78±91.42   2,575.48±84.35   2,734.56±93.37   2,632.92±92.39
                              Control       47             2,636.82±91.35   2,574.53±83.34   2,735.68±92.35   2,635.87±91.56
  CI (l/min·m^2^)             Observation   47             2.08±0.52        1.94±0.45        2.36±0.57        2.32±0.59
                              Control       47             2.02±0.55        1.92±0.44        2.38±0.58        2.37±0.56

###### 

Comparison of β-EP and MDA levels in the two groups.

                β-EP (pg/ml)                          MDA (nmol/l)                                    
  ------------- -------------- ------------- -------- -------------- ----------- ----------- -------- ---------
  Observation   106.82±7.72    192.73±6.82   57.176   \<0.001        1.26±0.53   3.48±1.02   13.240   \<0.001
  Control       106.72±7.67    151.32±6.73   29.965   \<0.001        1.25±0.65   6.24±1.07   27.325   \<0.001
  t value       0.063          29.629                                0.082       12.800               
  P-value       0.950          \<0.001                               0.935       \<0.001              

###### 

Comparison of adverse reactions after surgery in the two groups (n,%).

  Groups        No. of cases   Nausea and vomiting   Hypoxemia   Postoperative agitation   Delay in wakefulness
  ------------- -------------- --------------------- ----------- ------------------------- ----------------------
  Observation   47             3 (6.38)              1 (2.13)    1 (2.13)                  2 (4.26)
  Control       47             4 (8.51)              2 (4.26)    2 (4.26)                  3 (6.38)
  χ^2^ value                   0.001                 0.002       5.547                     0.001
  P-value                      0.999                 0.982       0.019                     0.999

###### 

Comparison of CRP levels in different periods of patients in the two groups (mg/l).

  Groups        No. of cases   Preoperative   Day 3                                                      Day 5                                                      Day 7
  ------------- -------------- -------------- ---------------------------------------------------------- ---------------------------------------------------------- ----------------------------------------------------------
  Observation   47             7.58±3.63      69.04±4.53^[a](#tfn1-etm-0-0-6993){ref-type="table-fn"}^   51.28±4.27^[a](#tfn1-etm-0-0-6993){ref-type="table-fn"}^   22.65±3.83^[a](#tfn1-etm-0-0-6993){ref-type="table-fn"}^
  Control       47             7.62±3.72      82.26±4.62^[a](#tfn1-etm-0-0-6993){ref-type="table-fn"}^   68.75±4.48^[a](#tfn1-etm-0-0-6993){ref-type="table-fn"}^   33.57±3.77^[a](#tfn1-etm-0-0-6993){ref-type="table-fn"}^
  t value                      0.053          14.007                                                     19.352                                                     13.930
  P-value                      0.958          \<0.001                                                    \<0.001                                                    \<0.001

P\<0.05, compared to the preoperative group.

###### 

Comparison of the patient TNF-α levels in different periods of in the two groups (ng/l).

  Groups        No. of cases   Preoperative   Day 3                                                      Day 5                                                      Day 7
  ------------- -------------- -------------- ---------------------------------------------------------- ---------------------------------------------------------- ----------------------------------------------------------
  Observation   47             6.36±3.53      83.73±5.14^[a](#tfn2-etm-0-0-6993){ref-type="table-fn"}^   55.27±4.28^[a](#tfn2-etm-0-0-6993){ref-type="table-fn"}^   26.38±3.46^[a](#tfn2-etm-0-0-6993){ref-type="table-fn"}^
  Control       47             6.41±3.72      95.25±5.65^[a](#tfn2-etm-0-0-6993){ref-type="table-fn"}^   68.75±4.19^[a](#tfn2-etm-0-0-6993){ref-type="table-fn"}^   35.43±3.75^[a](#tfn2-etm-0-0-6993){ref-type="table-fn"}^
  t value                      0.067          10.340                                                     15.429                                                     12.160
  P-value                      0.947          \<0.001                                                    \<0.001                                                    \<0.001

P\<0.05, compared to the preoperative group.

###### 

Comparison of the patient IL-6 levels in different periods in the two groups (ng/l).

  Groups        No. of cases   Preoperative   Day 3                                                       Day 5                                                        Day 7
  ------------- -------------- -------------- ----------------------------------------------------------- ------------------------------------------------------------ ----------------------------------------------------------
  Observation   47             15.42±3.84     112.13±6.16^[a](#tfn3-etm-0-0-6993){ref-type="table-fn"}^     98.56±5.25^[a](#tfn3-etm-0-0-6993){ref-type="table-fn"}^   58.62±4.68^[a](#tfn3-etm-0-0-6993){ref-type="table-fn"}^
  Control       47             15.37±3.72     127.54±6.74^[a](#tfn3-etm-0-0-6993){ref-type="table-fn"}^   109.63±5.42^[a](#tfn3-etm-0-0-6993){ref-type="table-fn"}^    69.54±4.65^[a](#tfn3-etm-0-0-6993){ref-type="table-fn"}^
  t value                      0.064          11.570                                                      10.058                                                       11.348
  P-value                      0.949          \<0.001                                                     \<0.001                                                      \<0.001

P\<0.05, compared to the preoperative group.

###### 

Postoperative outcomes of the two groups of patients.

  Groups        No. of cases   Time to taking food (h)   Time of getting out of bed (h)   The length of stay (days)
  ------------- -------------- ------------------------- -------------------------------- ---------------------------
  Observation   47             30.83±3.72                37.38±4.26                       13.32±1.25
  Control       47             45.15±3.65                49.56±4.38                       17.63±1.47
  t value                      18.837                    13.666                           15.313
  P-value                      \<0.001                   \<0.001                          \<0.001

###### 

Comparison of MoCA and MMSE scores in the two groups.

                MoCA (score)                        MMSE (score)                                      
  ------------- -------------- ------------ ------- -------------- ------------ ------------ -------- ---------
  Observation   28.83±1.52     26.95±1.72   7.203   \<0.001        30.48±1.53   26.38±1.56   11.613   \<0.001
  Control       28.82±1.63     25.32±1.74   9.718   \<0.001        29.97±1.61   23.23±1.57   18.512   \<0.001
  t value       0.079          4.189                               0.755          9.623               
  P-value       0.882          0.001                               0.572        \<0.001               
